107 related articles for article (PubMed ID: 28641455)
1. Modulation of cisplatin cytotoxic activity against leiomyosarcoma cells by epigallocatechin-3-gallate.
Dhima IT; Peschos D; Simos YV; Gkiouli MI; Palatianou ME; Ragos VN; Kalfakakou V; Evangelou AM; Karkabounas SC
Nat Prod Res; 2018 Jun; 32(11):1337-1342. PubMed ID: 28641455
[TBL] [Abstract][Full Text] [Related]
2. The green tea catechin epigallocatechin gallate induces cell cycle arrest and shows potential synergism with cisplatin in biliary tract cancer cells.
Mayr C; Wagner A; Neureiter D; Pichler M; Jakab M; Illig R; Berr F; Kiesslich T
BMC Complement Altern Med; 2015 Jun; 15():194. PubMed ID: 26100134
[TBL] [Abstract][Full Text] [Related]
3. Epigallocatechin-3-gallate potentiates curcumin's ability to suppress uterine leiomyosarcoma cell growth and induce apoptosis.
Kondo A; Takeda T; Li B; Tsuiji K; Kitamura M; Wong TF; Yaegashi N
Int J Clin Oncol; 2013 Jun; 18(3):380-8. PubMed ID: 22350026
[TBL] [Abstract][Full Text] [Related]
4. Potential mechanisms for the synergistic cytotoxicity elicited by 4-hydroxytamoxifen and epigallocatechin gallate in MDA-MB-231 cells.
Stuart EC; Larsen L; Rosengren RJ
Int J Oncol; 2007 Jun; 30(6):1407-12. PubMed ID: 17487361
[TBL] [Abstract][Full Text] [Related]
5. Synergistic effect of curcumin on epigallocatechin gallate-induced anticancer action in PC3 prostate cancer cells.
Eom DW; Lee JH; Kim YJ; Hwang GS; Kim SN; Kwak JH; Cheon GJ; Kim KH; Jang HJ; Ham J; Kang KS; Yamabe N
BMB Rep; 2015 Aug; 48(8):461-6. PubMed ID: 25441423
[TBL] [Abstract][Full Text] [Related]
6. Anti-melanoma effects of vorinostat in combination with polyphenolic antioxidant (-)-epigallocatechin-3-gallate (EGCG).
Nihal M; Roelke CT; Wood GS
Pharm Res; 2010 Jun; 27(6):1103-14. PubMed ID: 20232120
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of miR-126 sensitizes osteosarcoma cells to apoptosis induced by epigallocatechin-3-gallate.
Jiang L; Tao C; He A; He X
World J Surg Oncol; 2014 Dec; 12():383. PubMed ID: 25510179
[TBL] [Abstract][Full Text] [Related]
8. Green tea component, catechin, induces apoptosis of human malignant B cells via production of reactive oxygen species.
Nakazato T; Ito K; Ikeda Y; Kizaki M
Clin Cancer Res; 2005 Aug; 11(16):6040-9. PubMed ID: 16115949
[TBL] [Abstract][Full Text] [Related]
9. Epigallocatechin gallate acts synergistically in combination with cisplatin and designed trans-palladiums in ovarian cancer cells.
Mazumder ME; Beale P; Chan C; Yu JQ; Huq F
Anticancer Res; 2012 Nov; 32(11):4851-60. PubMed ID: 23155251
[TBL] [Abstract][Full Text] [Related]
10. Differential proteomic analysis reveals that EGCG inhibits HDGF and activates apoptosis to increase the sensitivity of non-small cells lung cancer to chemotherapy.
Flores-Pérez A; Marchat LA; Sánchez LL; Romero-Zamora D; Arechaga-Ocampo E; Ramírez-Torres N; Chávez JD; Carlos-Reyes Á; Astudillo-de la Vega H; Ruiz-García E; González-Pérez A; López-Camarillo C
Proteomics Clin Appl; 2016 Feb; 10(2):172-82. PubMed ID: 26175166
[TBL] [Abstract][Full Text] [Related]
11. Green tea polyphenol EGCG reverse cisplatin resistance of A549/DDP cell line through candidate genes demethylation.
Zhang Y; Wang X; Han L; Zhou Y; Sun S
Biomed Pharmacother; 2015 Feb; 69():285-90. PubMed ID: 25661371
[TBL] [Abstract][Full Text] [Related]
12. Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo.
Thangapazham RL; Singh AK; Sharma A; Warren J; Gaddipati JP; Maheshwari RK
Cancer Lett; 2007 Jan; 245(1-2):232-41. PubMed ID: 16519995
[TBL] [Abstract][Full Text] [Related]
13. The role of the mitochondrial oxidative stress in the cytotoxic effects of the green tea catechin, (-)-epigallocatechin-3-gallate, in oral cells.
Tao L; Forester SC; Lambert JD
Mol Nutr Food Res; 2014 Apr; 58(4):665-76. PubMed ID: 24249144
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory effects of (-)-epigallocatechin-3-gallate and pterostilbene on pancreatic cancer growth in vitro.
Kostin SF; McDonald DE; McFadden DW
J Surg Res; 2012 Oct; 177(2):255-62. PubMed ID: 22583593
[TBL] [Abstract][Full Text] [Related]
15. Epigallocatechin-3-gallate inhibits cell growth, induces apoptosis and causes S phase arrest in hepatocellular carcinoma by suppressing the AKT pathway.
Shen X; Zhang Y; Feng Y; Zhang L; Li J; Xie YA; Luo X
Int J Oncol; 2014 Mar; 44(3):791-6. PubMed ID: 24402647
[TBL] [Abstract][Full Text] [Related]
16. Epigallocatechin gallate sensitizes cisplatin-resistant oral cancer CAR cell apoptosis and autophagy through stimulating AKT/STAT3 pathway and suppressing multidrug resistance 1 signaling.
Yuan CH; Horng CT; Lee CF; Chiang NN; Tsai FJ; Lu CC; Chiang JH; Hsu YM; Yang JS; Chen FA
Environ Toxicol; 2017 Mar; 32(3):845-855. PubMed ID: 27200496
[TBL] [Abstract][Full Text] [Related]
17. Synergism from sequenced combinations of curcumin and epigallocatechin-3-gallate with cisplatin in the killing of human ovarian cancer cells.
Yunos NM; Beale P; Yu JQ; Huq F
Anticancer Res; 2011 Apr; 31(4):1131-40. PubMed ID: 21508356
[TBL] [Abstract][Full Text] [Related]
18. A combination of eicosapentaenoic acid-free fatty acid, epigallocatechin-3-gallate and proanthocyanidins has a strong effect on mTOR signaling in colorectal cancer cells.
D'Angelo L; Piazzi G; Pacilli A; Prossomariti A; Fazio C; Montanaro L; Graziani G; Fogliano V; Munarini A; Bianchi F; Belluzzi A; Bazzoli F; Ricciardiello L
Carcinogenesis; 2014 Oct; 35(10):2314-20. PubMed ID: 25123131
[TBL] [Abstract][Full Text] [Related]
19. Combination of low concentration of (-)-epigallocatechin gallate (EGCG) and curcumin strongly suppresses the growth of non-small cell lung cancer in vitro and in vivo through causing cell cycle arrest.
Zhou DH; Wang X; Yang M; Shi X; Huang W; Feng Q
Int J Mol Sci; 2013 Jun; 14(6):12023-36. PubMed ID: 23739680
[TBL] [Abstract][Full Text] [Related]
20. Pioglitazone induces cell growth arrest and activates mitochondrial apoptosis in human uterine leiomyosarcoma cells by a peroxisome proliferator-activated receptor γ-independent mechanism.
Lützen U; Zhao Y; Lucht K; Zuhayra M; Marx M; Cascorbi I; Culman J
Naunyn Schmiedebergs Arch Pharmacol; 2017 Jan; 390(1):37-48. PubMed ID: 27664035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]